A phase II trial of capecitabine and docetaxel followed by 5-fluorouracil/epirubicin/cyclophosphamide (FEC) as preoperative treatment in women with stage II/III breast cancer
Autor: | Jinno, H. *, Sakata, M., Hayashida, T., Takahashi, M., Mukai, M., Ikeda, T., Kitagawa, Y. |
---|---|
Zdroj: | In Annals of Oncology June 2010 21(6):1262-1266 |
Databáze: | ScienceDirect |
Externí odkaz: |